University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Antonio Westphalen, MD

Antonio Westphalen, MD

Associate Professor of Radiology and Biomedical Imaging; Director, Radiology and Biomedical Imaging, Clinical Prostate MR Imaging Program, UCSF

Cancer Center Program Memberships

Prostate Cancer

Research Summary

Antonio Westphalen, MD, MAS, PhD, is an Associate Professor in Residence in the Abdominal Imaging Section in the Department of Radiology and Biomedical Imaging and Urology at the University of California, San Francisco.

Dr. Westphalen received his medical degree from Universidade Federal do Rio Grande do Sul, Brazil in 1995, and completed his residency from the Instituto de Cardiologia do Rio Grande do Sul, Brazil and from the Hospital Moinhos de Vento, Brazil, followed by a fellowship in Abdominal Imaging at the University of California, San Francisco in 2005. Shortly after, Dr. Westphalen completed his MAS degree from the Master’s Degree Program in Clinical Research in the Department of Epidemiology and Biostatistics from UCSF. He received his PhD from the Doctoral Degree Program in Surgical Sciences, Urology at Universidade Federal do Sul, Brazil in 2012.

Dr. Westphalen is the Director of the Clinical Prostate MR Imaging Program and a member of the UCSF Department of Radiology’s Clinical Research Team and of the Prostate Cancer Imaging Group. Dr. Westphalen’s research emphasizes on the use of advanced imaging technologies to diagnose and treat patients with prostate cancer. Dr. Westphalen’s unique background has allowed him to expand his research and provide new expertise to the Prostate Cancer Imaging Group.

Dr. Westphalen has published over 100 articles related to his research, study cases, and reviews. His publications have appeared in the major journals in the fields of radiology, urology, and radiation oncology.

Education

  • Universidade Federal do Rio Grande do Sul, Brazil, M.D., 06/1995
  • Resident, Radiology, Instituto de Cardiologia do Rio Grande do Sul, Brazil, 06/1999
  • Resident, Radiology, Hospital Moinhos de Vento, Brazil, 06/2001
  • Clinical Fellow in Abdominal Imaging, Department of Radiology, UCSF, 06/2005
  • Clinical Fellow (T32 - NIH supported research year), Department of Radiology, UCSF, 06/2006
  • Master's Degree Program in Clinical Research, Dept of Epidemiology and Biostatistics, UCSF, M.A.S. 06/2011
  • Doctoral Degree Program in Surgical Sciences - Urology, Universidade Federal do Rio Grande do Sul, Brazil, Ph.D. 06/2013

Professional Experience

  • 2006-2012
    Assistant Professor in Residence, Radiology and Biomedical Imaging, Abdominal Imaging, University of California, San Francisco
  • 2012-present
    Associate Professor In Residence, Radiology and Biomedical Imaging, Abdominal Imaging Section & Department of Urology, University of California, San Francisco
  • 2015-present
    Director, Radiology and Biomedical Imaging, Clinical Prostate MR Imaging Program

Honors & Awards

  • 2013
    Selected as a speaker at the Society of Abdominal Radiology International Educational Conference, a collaborative educational program in which members travel to countries in Central and South America and provided lectures at the host country’s national or regional radiological meetings.
  • 2015
    Invited to speak at the plenary session of the Abdominal Radiology Course - Society of Abdominal Radiology - "Role of MR Imaging in Active Surveillance of Prostate Cancer"
  • 2016
    Keynote Speaker at the 2016 ARRS Annual Meeting. Imaging Differentiation of Diverticulitis from Colon Cancer. April 17-22, 2016, Los Angeles, CA.
  • 2016
    2016 Society of Abdominal Radiology Genitourinary Clinical Research Award. Rosenkrantz AB, Ginocchio LA, Cornfeld D, Froemming AT, Gupta RT, Turkbey B, Westphalen AC, Margolis D. Inter-observer Reproducibility of the PI-RADS Version 2 Lexicon: A Multi-Center Study of Six Experienced Prostate Radiologists.
  • 2016
    Radiological Society of North America Student Travel Award - Eric J. Jordan, MD (resident): Evaluating the Additional Utility of ADC Values to PI-RADS v2 - Role: mentor

Selected Publications

  1. Laguna B, Westphalen AC, Guimarães CT, Whang Z, Simko J, Zagoria R. Uncommon malignant renal tumors and atypical presentation of common ones: a guide for radiologists. Abdom Radiol (NY). 2018 Oct 11.
    View on PubMed
  2. Rocha TO, Albuquerque TC, Nather JC, Salmon CEG, Tucci S, Wang JZ, Westphalen AC, Elias J, Muglia VF. Histogram Analysis of Adrenal Lesions With a Single Measurement for 10th Percentile: Feasibility and Incremental Value for Diagnosing Adenomas. AJR Am J Roentgenol. 2018 Oct 09; 1-7.
    View on PubMed
  3. Gaur S, Lay N, Harmon SA, Doddakashi S, Mehralivand S, Argun B, Barrett T, Bednarova S, Girometti R, Karaarslan E, Kural AR, Oto A, Purysko AS, Antic T, Magi-Galluzzi C, Saglican Y, Sioletic S, Warren AY, Bittencourt L, Fütterer JJ, Gupta RT, Kabakus I, Law YM, Margolis DJ, Shebel H, Westphalen AC, Wood BJ, Pinto PA, Shih JH, Choyke PL, Summers RM, Turkbey B. Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? a multi-center, multi-reader investigation. Oncotarget. 2018 Sep 18; 9(73):33804-33817.
    View on PubMed
  4. Hicks RM, Simko JP, Westphalen AC, Nguyen HG, Greene KL, Zhang L, Carroll PR, Hope TA. Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer. Radiology. 2018 Sep 18; 180788.
    View on PubMed
  5. Muglia VF, Reis RB, Rocha TO, Silva AR, Noworolski S, Westphalen AC. Hypoenhancing prostate cancers on dynamic contrast-enhanced MRI are associated with poor outcomes in high-risk patients: results of a hypothesis generating study. Abdom Radiol (NY). 2018 Sep 18.
    View on PubMed
  6. Yeh BM, Obmann MM, Westphalen AC, Ohliger MA, Yee J, Sun Y, Wang ZJ. Dual Energy Computed Tomography Scans of the Bowel: Benefits, Pitfalls, and Future Directions. Radiol Clin North Am. 2018 Sep; 56(5):805-819.
    View on PubMed
  7. Kornberg Z, Cowan JE, Westphalen AC, Cooperberg MR, Chan JM, Zhao S, Shinohara K, Carroll PR. Genomic Prostate Score, PI-RADSv2, and Progression in Men with Prostate Cancer on Active Surveillance. J Urol. 2018 Sep 01.
    View on PubMed
  8. Furlan A, Borhani AA, Westphalen AC. Multiparametric MR imaging of the Prostate: Interpretation Including Prostate Imaging Reporting and Data System Version 2. Urol Clin North Am. 2018 Aug; 45(3):439-454.
    View on PubMed
  9. Wang ZJ, Westphalen AC, Zagoria RJ. CT and MRI of small renal masses. Br J Radiol. 2018 May 10; 20180131.
    View on PubMed
  10. Bonde AA, Johnson C, Addicott B, Westphalen AC, Korngold EK, Coakley FV. Case series of collapsed simple renal cysts potentially simulating cystic malignancy at CT. Clin Imaging. 2018 May 01; 50:297-301.
    View on PubMed
  11. Jordan EJ, Fiske C, Zagoria R, Westphalen AC. PI-RADS v2 and ADC values: is there room for improvement? Abdom Radiol (NY). 2018 Mar 17.
    View on PubMed
  12. Marcus SG, Candia S, Kohli MD, Mongan J, Zagoria RJ, Behr SC, Sun D, Westphalen AC. Association between misty mesentery with baseline or new diagnosis of cancer: a matched cohort study. Clin Imaging. 2017 Dec 15; 50:57-61.
    View on PubMed
  13. Furlan A, Borhani AA, Westphalen AC. Multiparametric MR imaging of the Prostate: Interpretation Including Prostate Imaging Reporting and Data System Version 2. Radiol Clin North Am. 2018 Mar; 56(2):223-238.
    View on PubMed
  14. Jordan EJ, Fiske C, Zagoria RJ, Westphalen AC. Evaluating the performance of PI-RADS v2 in the non-academic setting. Abdom Radiol (NY). 2017 Nov; 42(11):2725-2731.
    View on PubMed
  15. Leapman MS, Westphalen AC, Ameli N, Lawrence HJ, Febbo PG, Cooperberg MR, Carroll PR. Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa). PLoS One. 2017; 12(10):e0185535.
    View on PubMed
  16. Garcia-Reyes K, Nguyen HG, Zagoria RJ, Shinohara K, Carroll PR, Behr SC, Westphalen AC. Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy. J Urol. 2017 Sep 20.
    View on PubMed
  17. Lake ST, Greene KL, Westphalen AC, Behr SC, Zagoria R, Small EJ, Carroll PR, Hope TA. Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer. EJNMMI Res. 2017 Sep 19; 7(1):77.
    View on PubMed
  18. Leapman MS, Wang ZJ, Behr SC, Kurhanewicz J, Zagoria RJ, Carroll PR, Westphalen AC. Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancer. Radiol Bras. 2017 Sep-Oct; 50(5):299-307.
    View on PubMed
  19. Westphalen AC, Margolis DJA, Rosenkrantz AB. The Director of Prostate Imaging: advancing care for prostate cancer patients. Abdom Radiol (NY). 2017 Sep; 42(9):2358-2362.
    View on PubMed
  20. Cabarrus MC, Westphalen AC. Multiparametric magnetic resonance imaging of the prostate-a basic tutorial. Transl Androl Urol. 2017 Jun; 6(3):376-386.
    View on PubMed

Go to UCSF Profiles, powered by CTSI